🇺🇸 FDA
Patent

US 8716030

Means for the inhibition of anti-β1-adrenergic receptor antibodies

granted A61PA61P29/00A61P31/00

Quick answer

US patent 8716030 (Means for the inhibition of anti-β1-adrenergic receptor antibodies) held by Julius-Maximillians-Universitat Wurzburg, A Germany University expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Julius-Maximillians-Universitat Wurzburg, A Germany University
Grant date
Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P29/00, A61P31/00, A61P37/06, A61P43/00